Notes Receivable (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Notes Receivable [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Fair Value of the Convertible Notes Receivable | The fair value of the convertible notes receivable was estimated using a Monte Carlo Model with the following assumptions:
For the three months ended March 31, 2026, the fair value of each warrant granted with the convertible notes receivable was estimated using the assumption and/or factors in the Monte-Carlo Model as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Changes in the Evofem Notes | The following table sets forth a summary of the changes in the Evofem Notes:
|
|||||||||||||||||||||||||||||||||||||||||||||